FILE PHOTO: Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
SYDNEY (Reuters) - Australia's pharmaceutical regulator said on Thursday it is on course to review Pfizer's COVID-19 vaccine by January 2021, with the country sticking to a March timetable to start vaccinations.
Britain on Wednesday approved the use of the Pfizer vaccine, jumping ahead of the rest of the world in the race to begin the most crucial mass inoculation programme in history.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
